United States

Explore Related Locations

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Active Projects: 16

Project Investigator
All Locations Start date End date
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Trial (ADJUST) Nisha Acharya, MD United States
UCSF Research in Implementation Sciences for Equity (RISE 2) Kirsten Bibbins-Domingo, MD, PhD United States
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV Judith Hahn, PhD, MD United States
Traineeships in AIDS Prevention Studies Susan Kegeles, PhD United States
Mentoring Multidisciplinary Patient-Oriented Research in Liver Disease Mandana Khalili, MD United States
Ghosts and Angels in the Nursery: Exploration of Data Toward Development of An Instrument for Clinical Use Alicia Lieberman, PhD United States
Preschooler Witnesses of Domestic Violence Alicia Lieberman, PhD United States
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men Anne Luetkemeyer, MD United States
SF Bay Area MACS/WIHS Combined Cohort Study Phyllis Tien, MD United States
Cook County Clinical Research Site of the MACS/WIHS Combined Cohort Study Nancy Hessol, MSPH United States
Transdisciplinary Research Training to Reduce Disparities in Preterm Birth and Improve Maternal and Neonatal Outcomes Miriam Kuppermann, PhD, MPH United States
Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease Sulggi Lee, MD United States
Developmental Origin of Lineage Diversity in the Human Cerebral Cortex United States
Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, & Pharmacokinetics of Orally Administered ALS-008176 Regimens in Adults Hospitalized with Respiratory Syncytial Virus Steven Stoltz, MD United States
Substance Use Disorders Treatment/Services Research Training Program James L. Sorensen, PhD United States
An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged >14 years Presenting with Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC) Mohamed Fayed, MD United States

Archived Projects: 3381

Project Investigator
All Locations Start date End date
Enhanced Primary Care Nutrition and Screen Time Education to Prevent Obesity in Latino Infants United States
Global Strategic Information Finance analyst United States
Multicenter Study in treating Macular Edema Nisha Acharya, MD United States
Iontophoresis Delivery of Dexamethason Phosphate for Non-Infectious, No-Necrotizing Anterior Scieritis, Phase I Dose-Varying Study Nisha Acharya, MD United States
Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis Nisha Acharya, MD United States
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis (ADVISE) Trial Nisha Acharya, MD United States
Macular Edema Treatment Trials Associated with MUST (META-MUST) Nisha Acharya, MD United States
F.I. Proctor Foundation Uveitis Fellowship training program Nisha Acharya, MD United States
Phase 1 Iontophoretic Delivery of Dexamethasone for Tx of Anterior Scleritis Nisha Acharya, MD United States
Macular Edema Treatment Trials Associated with MUST (META-MUST) Nisha Acharya, MD United States
Clinical Research Fellowship for Nisha Acharya Nisha Acharya, MD United States
Effect of Ranibizumab on Refractory Macular Edema in Uveitis Phase I/II Nisha Acharya, MD United States
Age, Disruption, and Life Reorganization after Hurricane Katrina Vincanne Adams, PhD United States
Mentorship for -Managing Diagnostic Uncertainty: An Examination of the Interplay of Technology, Medical Knowledge, and Law in Diagnostic Practice. The Case of Epilepsy Vincanne Adams, PhD United States
Program in Global Health Diplomacy Vincanne Adams, PhD United States
Cap Independent Translation of Dengue Virus Raul Andino-Pavlovsky, PhD United States
Virus population dynamics, genetic diversity and evolution Raul Andino-Pavlovsky, PhD United States
Linking Virus Population Genetic Structure to Infectivity and Adaptation Raul Andino-Pavlovsky, PhD United States
Testing novel adjuvants to enhance mucosal immunity elicited by inactivated poliovirus vaccine (IPV) Raul Andino-Pavlovsky, PhD United States
Subcontract Work in Association with LLNL LDRD Project: COMP-08ERD036 Raul Andino-Pavlovsky, PhD United States
2013 NIH Workshop on Protein Homeostasis and Viral Infection Raul Andino-Pavlovsky, PhD United States
Replication fidelity mutants as attenuated poliovirus seeds for IPV production Raul Andino-Pavlovsky, PhD United States
Insect adaptive immunity Raul Andino-Pavlovsky, PhD United States
Genetic Diversity as a Determinant of Viral Pathogenesis and Attenuation Raul Andino-Pavlovsky, PhD United States
Quasispecies and drug resistance Raul Andino-Pavlovsky, PhD United States
A Collaborative Approach to the Design of a Genetically-Stable Oral Polio Vaccine (OPV-2) Raul Andino-Pavlovsky, PhD United States
Protein homeostasis mechanisms underlying enterovirus replication and evolution Raul Andino-Pavlovsky, PhD United States
EV71 intra-host evolution, attenuation and vaccine development Raul Andino-Pavlovsky, PhD United States
Mechanism of enterovirus replication Raul Andino-Pavlovsky, PhD United States
Mechansims of poliovirus replication Raul Andino-Pavlovsky, PhD United States
Genetic Diversity as a Determinant of Viral Adaptation and Pathogenesis Raul Andino-Pavlovsky, PhD United States
BSL3 upgrading for Live-attenuated poliovirus testing Raul Andino-Pavlovsky, PhD United States
INTERCEPT: Interfering and Co-evolving Prevention and Therapy Raul Andino-Pavlovsky, PhD United States
RAPID: Ebola virus population structure, genetic diversity and evolution Raul Andino-Pavlovsky, PhD United States
Selective AAK1 and GAK inhibitors for combating Dengue and other emerging viral infections Raul Andino-Pavlovsky, PhD United States
Recombinant Picornaviruses as AIDS Vaccines Raul Andino-Pavlovsky, PhD United States
RNAi as an Intercellular Antiviral Defense Mechanism Raul Andino-Pavlovsky, PhD United States
Vaccine to Prevent HIV Infection in Pregnancy and Newborns Raul Andino-Pavlovsky, PhD United States
RNA Protein Interactions in Poliovirus Replication Raul Andino-Pavlovsky, PhD United States
Song-Brown capitation funding for OB/GYN residency program Amy Autry, MD United States
Song Brown 2019 Amy Autry, MD United States
Song-Brown capitation funding for OB/GYN residency program Amy Autry, MD United States
Song-Brown capitation funding for OB/GYN residency program Amy Autry, MD United States
Testing Sponsor's Antiretroviral Enzyme Immunoassay Method Francesca Aweeka, PharmD United States
Pediatric AIDS Clinical Trial Group (PACTG) Pharmacology Support Laboratories Francesca Aweeka, PharmD United States
T004: BRS-IMPCT-Q-06-00119-T004-000 Francesca Aweeka, PharmD United States
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Francesca Aweeka, PharmD Malawi, Uganda, United States
T001: Adult AIDS Clinical Trials Group (AACTG): Pharmacology Laboratory Francesca Aweeka, PharmD Kenya, Malawi, Tanzania, Zambia, Zimbabwe, Botswana, South Africa, India, Thailand, Brazil, Peru, Haiti, Puerto Rico, United States
ACTG: AIDS Clinical Trials Group; MASTER SUBCONTRACT -- U01AI068636 Francesca Aweeka, PharmD Malawi, Zambia, Botswana, South Africa, India, Thailand, United States
Quality Assurance/Quality Control Program Francesca Aweeka, PharmD United States
AIDS Clinical Trials Group Network Francesca Aweeka, PharmD United States
DDI study between HIV drugs (Efavirenz) and Coartem Francesca Aweeka, PharmD United States
Raltegravir (MK-518) Francesca Aweeka, PharmD United States
2 year joint fellowship program in Clinical Pharmacy with Actelion Francesca Aweeka, PharmD United States
Lopinavir Test Comparison to LCMS Francesca Aweeka, PharmD United States
Regulatory Networks That Control Cell Morphology and Virulence in the Fungal Respiratory Pathogen Histoplasma capsulatum United States
Regulatory Circuits That Link Cell Fate and Virulence in Histoplasma Capsulatum United States
Regulation of Virulence Traits in a Fungal Pathogen of Cancer Patients United States
Hypertension Management in Minority and Low-income Populations Kirsten Bibbins-Domingo, MD, PhD United States
Outcomes Modeling for VA Return on Investment Analysis Kirsten Bibbins-Domingo, MD, PhD United States
Chronic Kidney Disease and Cardiovascular Risk in Black and White Young Adults Kirsten Bibbins-Domingo, MD, PhD United States
Adapting of the Coronary Heart Disease Policy Model to U.S. Subpopulations Kirsten Bibbins-Domingo, MD, PhD United States
NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (U54) Kirsten Bibbins-Domingo, MD, PhD United States
NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (U54)-Research Enrichment Core Kirsten Bibbins-Domingo, MD, PhD United States
Barber-Pharmacist Coordination to Improve Bldd Pressure Management in Black Men Kirsten Bibbins-Domingo, MD, PhD United States
NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (U54)-Student Training Core Kirsten Bibbins-Domingo, MD, PhD United States
Preventable Hospitalizations and Racial Disparities in Heart Failure Kirsten Bibbins-Domingo, MD, PhD United States
Precision Public Health Conference Kirsten Bibbins-Domingo, MD, PhD United States
Antecedents of Heart Failure among African American and White Young Adults Kirsten Bibbins-Domingo, MD, PhD United States
Addressing Disparities in Chronic Disease with a Teen and Young Adult Focus Kirsten Bibbins-Domingo, MD, PhD United States
Discovering Healthcare Innovations to Address Disparities in Stroke (DIADS) Kirsten Bibbins-Domingo, MD, PhD United States
Addressing Disparities in Chronic Disease with a Teen and Young Adult Focus Kirsten Bibbins-Domingo, MD, PhD United States
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases Kirsten Bibbins-Domingo, MD, PhD United States
Occupational and Environmental Factors in Neurological Disease Paul Blanc, MSPH, MD United States
Coal Mining Employment as a Risk Factor for Rheumatoid Arthritis - Second Phase Paul Blanc, MSPH, MD United States
Northern California Education and Resource Center Paul Blanc, MSPH, MD United States
Northern California Education & Resources Center - TRT, OEM at UCSF Paul Blanc, MSPH, MD United States
Occupational and Environmental Determinants of Health Paul Blanc, MSPH, MD United States
Estimating the Environmental Burden in Two Orphan Lung Diseases Paul Blanc, MSPH, MD United States
New Technologies, Novel Diseases: Industrial Illness in 20th Century Rayon Manufacturing Paul Blanc, MSPH, MD United States
Coal Mining Risk of Arthritis, Including Auto-Immune Rheumatologic Disease Paul Blanc, MSPH, MD United States
Intervention to Decrease Risk for STDs and Unintended Pregnancies in Active Duty Military Women United States
Technical and Logistical Support for the Office of AIDS Research United States
Adolescent Medicine Trials Network for HIV/AIDS United States
Adolescent Trials Network United States
Leadership Group for the Adolescent Medicine Trials Network United States
Preventing Health Damaging Behaviors and Negative Health Outcomes in Army and Marine Corps Personnel during the First Tour of Duty United States
Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children Esteban Burchard, MD, MPH United States
Genes, air pollution, and asthma severity in minority children Esteban Burchard, MD, MPH United States
New York Center for Collaborative Research in Common Disease Genomics Esteban Burchard, MD, MPH United States
Integrative Analyses to Uncover Biological Mechanisms Mediating Gene Associations with Asthma Drug Response Among Minority Children Esteban Burchard, MD, MPH United States
The EVE Asthma Genetics Consortium: Building Upon GWAS Esteban Burchard, MD, MPH United States
Bay Area Research Consortium on Toxic Stress and Health Esteban Burchard, MD, MPH United States
Genetics of Asthma in Latino Americans Esteban Burchard, MD, MPH United States
Center for Multi- and Trans-ethnic Mapping of Mendelian and Complex Diseases Esteban Burchard, MD, MPH United States
Clinical Pharmacology, Drug Action and Pharmacogenetics Esteban Burchard, MD, MPH United States
Clinical Pharmacology, Drug Action and Pharmacogenetics Esteban Burchard, MD, MPH United States
Air pollution, tobacco smoke, & asthma in minority children Esteban Burchard, MD, MPH United States
Case-Control Association Studies and Genetic Confounding Esteban Burchard, MD, MPH United States
Genetic Control of Airway Epithelium Gene Expression in Childhood Asthmatics Esteban Burchard, MD, MPH United States
Pharmacogenomics of Bronchodilator Response in Minority Children with Asthma Esteban Burchard, MD, MPH United States
UCSF-Genentech Asthma Collaboration Task Order Esteban Burchard, MD, MPH United States
Gene-Environment Analyses of Early Life Exposures and Asthma in Ethnically Diverse Children Esteban Burchard, MD, MPH United States
Addressing Oral Health Literacy among Mexican Immigrants Nancy Burke, PhD United States
Filipina Breast Cancer Support: Which Model is Meaningful? [2] Nancy Burke, PhD United States
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [II] Nancy Burke, PhD United States
Health literacy systems in the safety net: Lessons from complex care management Nancy Burke, PhD United States
Filipina Breast Cancer Support: What Model is Meaningful? [1] Nancy Burke, PhD United States
Buong Puso: Linking Filipinas with Breast Cancer to Care and Support Resources Nancy Burke, PhD United States
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [I] Nancy Burke, PhD United States
Sinag Tala (Bright Star): Pilipina Breast Cancer Support Group Outreach Nancy Burke, PhD United States
Exploring Statins As a Small Molecule Therapy for Treatment of Schistosomiasis United States
An Automated High Throughput Phenotypic Screen for Schistosomiasis Drug Discovery United States
Schistosoma mansoni: Identification and Validation of New Targets for Therapy Using a siRNA Screen United States
Stanford Global Health Consortium: Innovation, Design, Evaluation and Action United States
A schistosome cysteine protease in Th response polarization United States
Identifying inhibitors of Parasitic Worm Activity United States
Modeling the Reproducibility of Blood Assays for TB Infection Adithya Cattamanchi, MD United States
Automated smear-positive tuberculosis diagnosis Adithya Cattamanchi, MD United States
A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis Adithya Cattamanchi, MD United States
TB Diagnosis Technology Adithya Cattamanchi, MD United States
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus, Continuation A120553 Henry Chambers, MD United States
Study for Sample Acquisition for Patients Diagnosed with S. aureus Bacteremia Henry Chambers, MD United States
Novel Mechanisms of Beta-Lactam Resistance in Staph Aureus Henry Chambers, MD United States
Phase 2 Study, Safety of and Rate of Bacterial Clearance of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD United States
Epidemiologic Analysis of Data from Project Aware to Determine the Impact of Different HIV Testing Strategies on Risk Behaviors and STD Rates among HIV-Uninfected MSM Henry Chambers, MD United States
A Multi-Center, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Patients with Blood Stream Infections due to Staphylococci. Henry Chambers, MD United States
Biology of Infectious Diseases Training Program [II] Henry Chambers, MD United States
Biology of Infectious Diseases Training Program Henry Chambers, MD United States
Penicillin Interactive Proteins of Staphylococcus Aureus Henry Chambers, MD United States
Antibacterial Resistance Leadership Group (ARIG) Henry Chambers, MD United States
Applied Research on Antimicrobioal Resistance: Molecular Epidemiology of Community Methicillin-resistant Staphylococcus aureus (MRSA) Henry Chambers, MD United States
Tetrezolid vs. Daptomycin and Vancomycin for Treatment of Experimental Staphylococcus aureus Henry Chambers, MD United States
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus Henry Chambers, MD United States
Protocol Development for a Phase 2 Study Evaluating the Safety and Feasibility of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD United States
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Henry Chambers, MD United States
Ceftaroline Fosamil in Subjects With Staphylococcus aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Henry Chambers, MD United States
Biology of Infectious Diseases Training Program Henry Chambers, MD United States
Proposed Experiments to Study Emergence of Antimicrobial Resistance in Methicillin- Resistant Strains of Staphylococcus aureus Henry Chambers, MD United States
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 Henry Chambers, MD United States
Efficacy Evaluation and Safety of Single-dose IV Oritavancin vs. IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin Structure Infection (SOLO I) Henry Chambers, MD United States
Phase III Study: Safety & Efficacy of Daptomycin Compared to Conventional Therapy in the Treatment of Subjects w/ infective endocarditis or bacteremia due to Staphylococcus aureus Henry Chambers, MD United States
Ceftobiprole vs. Daptomycin and Linezolid for Treatment of Experimental Staph. aureus Endocarditis in Rabbits Henry Chambers, MD United States
Biology of Infectious Diseases Training Program [I] Henry Chambers, MD United States
Biology of Infectious Diseases Training Program [III] Henry Chambers, MD United States
A Phase 2, Randomized, Open-Labeled Study on the Safety of and Rate of Bacterial Clearance of Ceftobiprole Compared to Conventional Therapy in the Treatment of Subjects w/ Staphylococcus aureus Bacteremia Henry Chambers, MD United States
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections Henry Chambers, MD United States
Novel Mechanisms of Beta-Lactam Resistance in Staph aureus Henry Chambers, MD United States
Getting to Zero: Advancing Retention and Re-Engagement in HIV Care Demonstration Project Edwin Charlebois, PhD United States
Structural Alcohol/HIV RIsk Intervention in Gay Bar Patrons Edwin Charlebois, PhD United States
Structural Alcohol/HIV Risk Intervention in Gay Bar Patrons Edwin Charlebois, PhD United States
Structural Alcohol Intervention to Reduce HIV Risk Behavior among Gay Bar Patrons Edwin Charlebois, PhD United States
Novel Evaluation Methods for Multi-Level/Combination HIV Prevention Interventions Edwin Charlebois, PhD United States
Enhancing Care Engagement and Re-engagement Edwin Charlebois, PhD United States
Simcere Surpi eval project Charles Chiu, MD, PhD United States
Pathogen discovery and epidemiology in tick vectors associated with Lyme-like diseases Charles Chiu, MD, PhD United States
Virus Detection Using Microarrays and Characterization of a Novel Cardiovirus Charles Chiu, MD, PhD United States
Identification of diagnostic and prognostic host biomarkers of Zika virus infection by transcriptome profiling Charles Chiu, MD, PhD United States
Metagenomics for Identification of Infectious Triggers of KLS Charles Chiu, MD, PhD United States
Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents Charles Chiu, MD, PhD United States
A Combined Pathogen-Host Sequencing Assay for Diagnosis of Lyme and Other Tickborne Infections Charles Chiu, MD, PhD United States
Establishing a Core Facility for Virus Detection and Discovery Charles Chiu, MD, PhD United States
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing Charles Chiu, MD, PhD United States
Comprehensive Diagnostics for Viral Encephalitis/Meningitis Charles Chiu, MD, PhD United States
CCD Study- RNA Sequencing Charles Chiu, MD, PhD United States
Multiplexed Viral and Cytokine Response Assays Using NanoString Technology Charles Chiu, MD, PhD United States
Real-Time Detection of Bloodborne Pathogens by Unbiased Nanopore Sequencing 20150506 Charles Chiu, MD, PhD United States
Comprehensive Diagnostics for Viral Encephalitis/Meningitis Charles Chiu, MD, PhD United States
To Discover and Characterize Novel Viruses in Cancer Charles Chiu, MD, PhD United States
Identification of Viruses in an Asthma Cohort Charles Chiu, MD, PhD United States
Identification of Signaling Pathways Associated with Lyme Disease Charles Chiu, MD, PhD United States
Pathogen characterization and discovery by deep sequencing of two major vectors associated with Lyme disease and other tickborne infections Charles Chiu, MD, PhD United States
Whole Blood/Serum Samples from Patients with Hepatitis Charles Chiu, MD, PhD United States
Using Pan-Pathogen Microarrays and Deep Sequencing to Search for the Cause of Southern Tick-Associated Rash Illness (STARI) Charles Chiu, MD, PhD United States
Social/Sexual Networks & HIV Risk: Men of Color Kyung-Hee Choi, MPH, PhD United States
Countering a Hidden Risk: Initiating Change Among Methamphetamine-Using MSM Kyung-Hee Choi, MPH, PhD United States
Developing a Network Intervention to Promote Women's Health Kyung-Hee Choi, MPH, PhD United States
Asian Men's Health Study Kyung-Hee Choi, MPH, PhD United States
Female Condom Intervention Trial Kyung-Hee Choi, MPH, PhD United States
The Medical Consequences of Different Types of Heroin Daniel Ciccarone, MD, MPH United States
Heroin Price, Purity, and Outcomes Study Daniel Ciccarone, MD, MPH United States
Heroin in Transition Daniel Ciccarone, MD, MPH United States
AIDS Education and Training Center (AETC) National Resource Center / Website Susan Coffey, MD United States
Women, Children, and HIV Website Susan Coffey, MD Kenya, Malawi, Mauritius, Mozambique, Rwanda, Seychelles, Somalia, Uganda, Tanzania, Zambia, Zimbabwe, Angola, Cameroon, Central African Republic, Chad, Botswana, Lesotho, Namibia, South Africa, Swaziland, Gambia, Ghana, Liberia, Nigeria, India, Pakistan, Sri Lanka, Singapore, Philippines, United Kingdom, Anguilla, Antigua and Barbuda, Bahamas, Barbados, Cayman Islands, Dominica, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Trinidad and Tobago, U.S. Virgin Islands, Northern Mariana Islands, Australia, Marshall Islands, Palau, Papua New Guinea, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu
HIV Clinical Fellowship 2018 (Fellow May Baca) Susan Coffey, MD United States
National Resource Center for HIV/AIDS Prevention among Adolescents (APNRC) Susan Coffey, MD United States
HIV-HEP C Website Maintenance Services Susan Coffey, MD United States
HIVMA Clinical Fellowship Program (Baca) Susan Coffey, MD United States
AETC National Coordinating Resource Center, Center for HIV Information UCSF S. Coffey Susan Coffey, MD United States
HepC/HIV website Susan Coffey, MD United States
AETC National Resource Center / AIDS Education and Training Website Susan Coffey, MD United States
Women, Children, and HIV Website Susan Coffey, MD United States
VA HIV-HEP C Website Maintenance Services Susan Coffey, MD United States
Adolescent Modules - AETC Web Site Susan Coffey, MD United States
Adolescent Modules - AETC Web Site (Cont.) Susan Coffey, MD United States
VA HIV Website Susan Coffey, MD United States
Women, Children, and HIV Website (DBS) Susan Coffey, MD United States
Vaginal Use of Lactobacillus crispatus in Women, Safety Trials Craig Cohen, MD, MPH United States
Preclinical Development of MucoCept Craig Cohen, MD, MPH United States
RTI Subcontract Back to UCSF Craig Cohen, MD, MPH United States
Development of a Live Topical Microbicide for Women Craig Cohen, MD, MPH United States
Satellite Symposium at Microbicides 2010 on Bacterial Therapeutics Craig Cohen, MD, MPH United States
Development of a Live Topical Microbicide for Women Craig Cohen, MD, MPH United States
Phase II-b Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus Crispatus CTV-05 Craig Cohen, MD, MPH United States
Reproductive Infectious Disease (RID) Fellowship Craig Cohen, MD, MPH United States
Host-Directed Strategies to Create Synergistic Antibacterial Therapies United States
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages United States
Manipulation of Macrophage Responses by M. tuberculosis United States
Role of MmpL Transporters in M. Tuberculosis Virulence United States
Determination of the M. tuberculosis proteome interaction map (iMAP) during persistence United States
Regulation of ESX-1 secretion and its role in M. tuberculosis virulence United States
Targeting host autophagy for treating Mtb infections and synergizing with antibiotics in vivo United States
Manipulation of Macrophage Responses by M. tuberculosis United States
Manipulation of Macrophage Responses by M. Tuberculosis United States
Regulation of ESX-1 Secretion and Its Role in Mycobacterium tuberculosis Virulence United States
Secretion of Virulence Factors by Mycobacterium tuberculosis United States
Uncovering How Mycobacterium Tuberculosis Utilizes a Novel Protein Secretion System to Manipulate Host Response During Infection United States
Structural Genomics of Persistence Targets from M. Tuberculosis United States
A pilot study of DNA methylation and response to treatment in RA United States
The contribution of epigenetics to SLE phenotype and outcome United States
Admixture Mapping Development and Testing in African American SLE United States
Novel Strategies for defining the Role of HLA in SLE United States
Dissecting the HLA Contribution to Rheumatoid Arthritis United States
Health Professional Research Preceptorship United States
Immunogenetic Studies of Autoimmune Disease United States
Kirkland Scholar Award 2005 United States
Health Professional Research Preceptorship United States
Task Order Number #2 - Development United States
Health Professional Research Preceptorship United States
Genetic Predictors of Thrombosis in Systemic Lupus Erythmatosus United States
The Role of a PARP1 Genetic Variant in Development of Lupus United States
Dissecting the HLA contribution to Rheumatoid Arthritis United States
Health Professional Research Preceptorship United States
DNA methylation profiling in Rheumatoid Arthritis United States
Mother-child genetic contributions to autoimmunity United States
Medical and Graduate Student Preceptorship - Mok United States
New Challenges in HIV Prevention for Gay Male Couples Lynae Darbes, PhD United States
Longitudinal Study of Gay Male Couples Lynae Darbes, PhD United States
Frontloaded Sputum Microscopy United States
A Novel Proteomic Approach to Tuberculosis Biomarker Discovery using Human Exosomes United States
Clinical and Public Health Impact of Automated Nucleic Acid Testing (Cepheid GeneXpert) to Rule-out Tuberculosis in San Francisco United States
Exosomes as Biomarkers for Tuberculosis United States
Prevention for HIV-Positive Persons: An Intervention for HIV Care Providers Carol Dawson-Rose, RN, PhD, FAAN United States
Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting Carol Dawson-Rose, RN, PhD, FAAN United States
Prevention with Positives Carol Dawson-Rose, RN, PhD, FAAN United States
SBIRT Interdisciplinary Training Program Carol Dawson-Rose, RN, PhD, FAAN United States
North American Consortium of Global Health Academic Programs Organizing Meeting Haile Debas, MD United States
U.C.-Wide School of Global Health Planning Haile Debas, MD United States
DCP3 Surgery Volume Haile Debas, MD United States
Senior leadership advisor for the Institute for Global Health Sciences Haile Debas, MD United States
School of Global Health Health Planning: Centers of Expertise Development Haile Debas, MD United States
Global Health Sustainability: Focusing on the Workforce Haile Debas, MD United States
HIV Persistence after Successful CCR5-Depleted Stem Cell Transplantation Steven Deeks, MD United States
Elite Controllers Steven Deeks, MD United States
Characterizing the Role of Immune Activation in HIV Persistence Steven Deeks, MD United States
Identifying and targeting HIV persistence in T Cell subsets during ART Steven Deeks, MD United States
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node Steven Deeks, MD United States
Task Order: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven Deeks, MD United States
Programming Long Term Durable HIV-1 Specific T cell Responses Steven Deeks, MD United States
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir Steven Deeks, MD United States
Atripla Adherence and Resistance Relationships [II] Steven Deeks, MD United States
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients Steven Deeks, MD United States
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease Steven Deeks, MD United States
HIV Entry Inhibitors: A New Therapeutic Option Steven Deeks, MD United States
Impact of Sex-Based Differences on HIV Reservoir Size and Immune Activation Steven Deeks, MD United States
UCSF/Ragon Collaboration on HIV "Elite" Controllers Steven Deeks, MD United States
Identifying and Targeting HIV Persistence in T Cell Subsets during ART Steven Deeks, MD United States
Master Agreement: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven Deeks, MD United States
Epigenetic Regulation of HIV Latency Steven Deeks, MD United States
Atripla Adherence and Resistance Relationships [I] Steven Deeks, MD United States
HIV Controllers: A Potential Model for HIV Eradication Steven Deeks, MD United States
Preventing the Establishment of Enfuvirtide-Resistance in the Latent Reservoir Steven Deeks, MD United States
Combination immune checkpoint blocker inhibition to eliminate HIV latency Steven Deeks, MD United States
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296 Steven Deeks, MD United States
Validation of Existing Ultra-Sensitive Assays for Quantifying HIV Persistence Steven Deeks, MD United States
Impact of HIV-Associated Inflammation on Disease Steven Deeks, MD United States
Core B: Specimen Repository Core Steven Deeks, MD United States
Enhancing Control of HIV by Inhibiting TRAIL Steven Deeks, MD United States
Delaney AIDS Research Enterprise to Cure HIV Steven Deeks, MD United States
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response Steven Deeks, MD United States
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen Steven Deeks, MD United States
GS-US-382-3961: A Phase 1b, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of GS-9620 in Antiretroviral Treated HIV-1 Infected Controllers Steven Deeks, MD United States
Treating HIV-infected Elite Controllers as a Model of HIV Remission Steven Deeks, MD United States
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes Steven Deeks, MD United States
EraMune Project Steven Deeks, MD United States
HIV Specific T-Cell Responses in Rectal Mucosa Steven Deeks, MD United States
Therapeutic vaccination and PD-1 blockade in treated HIV disease Steven Deeks, MD United States
Short-Term Disulfiram Administration to Reverse Latent HIV Infection Steven Deeks, MD United States
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven Deeks, MD United States
T Regulatory Cells and T Cell Activation in HIV Disease Steven Deeks, MD United States
Deeks Order CNICS: June 2014-Aug 2016 Steven Deeks, MD United States
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven Deeks, MD United States
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20 Steven Deeks, MD United States
Measuring the Latent reservoir for HIV Steven Deeks, MD United States
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV Steven Deeks, MD United States
Long Term Follow-Up of Patients Enrolled in Clinical Trials (#A-9602, A-9604, A-9801) Using Retroviral Gene Based Therapies / AIDS related research Steven Deeks, MD United States
Innate Effector Function and HIV-1 Control Steven Deeks, MD United States
Treatment Intensification for Drug-Resistant HIV Steven Deeks, MD United States
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven Deeks, MD United States
Disulfiram to Accelerate Decay in HIV Reservoirs in ART Treated Patients Steven Deeks, MD United States
Molecular Engineering of Erythrotropic Bacteria for Treatment and Prevention of Human Malaria Joseph Derisi, PhD United States
UCDRD Whitepaper: Viral Pathogens Joseph Derisi, PhD United States
The Microbiome, Virome and Host Response in Ventilator Associated Pneumonia Joseph Derisi, PhD United States
Development of Proteome-scale Peptide Bead Suspension Arrays for Immunoprofiling and Vaccine Development by Multi Channel Microfludic Flow Sorting. Joseph Derisi, PhD United States
Integrative Program in Complex Biological System (ipCBS) Joseph Derisi, PhD United States
Integrative Program in Complex Biological System (ipCBS) Joseph Derisi, PhD United States
Core B: Intracellular Pathogens and Innate Immunity Joseph Derisi, PhD United States
A Functional Genomics Approach to Identification of New Anti-Malarial Drug Targets Joseph Derisi, PhD United States
Genomic Technology Development and Infectious Diseases Joseph Derisi, PhD United States
CORE B: Intracellular Pathogens and Innate Immunity Joseph Derisi, PhD United States
A Genome Wide Characterization of the Erythrocytic Cell Cycle of the Human Parasite Plasmodium Joseph Derisi, PhD United States
Development of Anti-Malarial Preclinical Candidates Joseph Derisi, PhD United States
Novel Anti-Malarials by Combinatorial Pharmacogenomics Joseph Derisi, PhD United States
Framework to Address Drug Resistant Infections and Global Health Joseph Derisi, PhD United States
Discovery of Novel Molecular Abnormalities Underlying Non-Lesional Focal Epilepsy Joseph Derisi, PhD United States
Using Apicoplast-Deficient Parasites to Identify Anti-Malaria Compounds That Specifically Target This Organelle Joseph Derisi, PhD United States
Homeless Female Offenders Returning to the Community: Improving Hopeful Futures Maria Ekstrand, PhD United States
Homeless Female Offenders Returning to the Community: Improving Hopeful Futures Maria Ekstrand, PhD United States
High throughput proteomics to dissect Chlamydia-host cell interactions Joanne Engel, MD, PhD United States
Adapting to a changing environment: How surface contact induces virulence factor production in Pseudomonas aeruginosa Joanne Engel, MD, PhD United States
Novel approaches to identify host genes required for Chlamydia pathogenesis Joanne Engel, MD, PhD United States
New approaches to study Pseudomonas-host interactions Joanne Engel, MD, PhD United States
Microbial Pathogenesis and Host Defense Joanne Engel, MD, PhD United States
Microbial Pathogenesis and Host Defense Joanne Engel, MD, PhD United States
Scholars in Health Policy Research Program United States
Culture-Based Prediction of Adolescent HIV Risk Behavior United States
Protein Carbohydrate Interactions in the Pathophysiology of Asthma Exacerbations United States
Characterizing the Rheological Properties of Cystic Fibrosis Sputum and the Effects of Mucoactive Agents. United States
Preventing Fucose-Dependent Binding of Aspergillus and Pseudomonas to Lung Mucin United States
Histoblood Group Antigens, Viruses and Asthma Exacerbation United States
Innate and Adaptive Immune Responses in TH2-High Asthma United States
T Cell Inflammation and Mucin Hypersecretion in COPD United States
Clinical and Molecular Phenotypes of Severe Asthma United States
Airway Transcriptome Changes in Smokers United States
Core Laboratory for Sputum Quality Assurance and Sputum Analysis United States
Compilation, Synthesis and Grading of Evidence for Questions 5 and 6 Elizabeth Fair, PhD, MPH United States
Core Requirements: Tuberculosis Epidemiologic Studies Consortium Elizabeth Fair, PhD, MPH United States
Evaluation of interferon Gamma Release Assays in Overseas Immigration Examination of Children in Moderate and high Burden Countries Elizabeth Fair, PhD, MPH United States
Evidence for Global Health Advocacy Richard Feachem, DSc, PhD United States
PwC/UCSF Fellowship Program Agreement Richard Feachem, DSc, PhD United States
The Center for Policy Impact in Global Health & the Capstone Year (phase IV) of the Commission on Investing in Health Richard Feachem, DSc, PhD United States
Grant to support UCSF Global Health Impact Fund Richard Feachem, DSc, PhD United States
The Global Health Group - From Analysis to Action Richard Feachem, DSc, PhD United States
Mentoring the mentors in California to enhance diversity in the biomedical research workforce Mitchell Feldman, MD United States
Molecular Mechanisms of Plasmodium falciparum Adherence to the Human Placenta Susan Fisher, PhD United States
Insights into Plasmodium falciparum Interactions with the Human Placenta Susan Fisher, PhD United States
VEGF signaling in placental development and disease Susan Fisher, PhD United States
Dissecting Gene Dysregulation at the Maternal-Fetal Interface in Preeclampsia Susan Fisher, PhD United States
Specialty in Stem Cell Biology Susan Fisher, PhD United States
Credentialing Banked Placental Biospecimen Quality Susan Fisher, PhD United States
Biomarkers of gestational age that circulate in a woman's blood Susan Fisher, PhD United States
Training Program in Stem Cell Research at UCSF Susan Fisher, PhD United States
Dissecting gene dysregulation at the maternal-fetal interface in preeclampsia Susan Fisher, PhD United States
A Novel Model for Assessing the Effects of BPA Exposures on Human Placentation Susan Fisher, PhD United States
Functional Glycomics of Human Saliva Susan Fisher, PhD United States
Denial of Legal Abortion and Implications for Quality of Care Diana Foster, PhD United States
Study of Uptake, Continuation and Removal of the IUC Diana Foster, PhD United States
Turnaway Study: Continuation, Dissemination, and Expansion Diana Foster, PhD United States
Refugee Health United States
Sedation management in pediatric patients with acute respiratory failure Linda Franck, RN, PhD, FAAN United States
The Child and Family Hospital Experience: Is it influenced by family accommodation? Linda Franck, RN, PhD, FAAN United States
Reducing neonatal mortality and morbidity Linda Franck, RN, PhD, FAAN United States
Ronald McDonald House Charities: Global Impact Study Linda Franck, RN, PhD, FAAN United States
Translating Discoveries in Neurological Diseases of Infancy and Childhood Heather Fullerton, MD United States
Predicting Stroke after Trauma (PSAT) Heather Fullerton, MD United States
Predicting epilepsy after traumatic brain injury in children and young adults: A population based study Heather Fullerton, MD United States
The role of infection in childhood stroke Heather Fullerton, MD United States
The Vascular effects of Infection in Pediatric Stroke (VIPS II) Study Heather Fullerton, MD United States
DIADS Project 2: Racial Disparities in Ischemic Stroke and Atherosclerotic Risk Factors in the Young Heather Fullerton, MD United States
Prevention of Stroke after STOP Heather Fullerton, MD United States
Measuring TB Drugs in Hair as a Tool to Monitor Adherence, Exposure and Response Monica Gandhi, MD, MPH United States
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence Monica Gandhi, MD, MPH United States
AIDS Clinical Trials Group Monica Gandhi, MD, MPH United States
Hair measures to assess adherence and explain outcomes in an HIV clinical trial Monica Gandhi, MD, MPH United States
Developing a Mentoring Network of Diverse Mental Health Professionals Utilizing the CNICS Platform Monica Gandhi, MD, MPH United States
Assessing Antiretroviral Exposure in Diverse Populations Monica Gandhi, MD, MPH United States
Hair Extensions;: Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables Monica Gandhi, MD, MPH United States
HIV Clinical Fellowship Monica Gandhi, MD, MPH United States
Positive Health Access to Services and Treatment (PHAST) Monica Gandhi, MD, MPH United States
Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare Monica Gandhi, MD, MPH United States
Determination of Reyataz (Atazanavir Sulfate) Levels in Hair: A New Assay and Possible Predictor for Long-Term Virologic Outcome Monica Gandhi, MD, MPH United States
Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM Monica Gandhi, MD, MPH United States
Family Services Network - Ryan White HIV/AIDS Program Monica Gandhi, MD, MPH United States
Herpesviral Gene Expression in Kaposi's Sarcoma United States
Geng Work Order CNICS: Crane R56 MI Packets United States
CFAR Network (CNICS) Research Platform: Channeling Bias Study United States
Geng's work Order fee for Service Agreement / BMS MI A1424-562 United States
Work Order for CNICS Admin Core 5 Years (related to NIH R24 A1067039) United States
R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS United States
R24 for the CFAR-Network for the Integrated Clinical Science, CNICS United States
Health Qual Impact Evaluation (HQIE) United States
Geng Work Order RTI Health Solutions (Services for RTI/ViiV) United States
Quality Improvement Evaluation Center (Q-IEC) United States
Develop and host an open-access web-based database of implementation science research related to the HIV cascade of care United States
Predicting Progression of Human Prion Disease Michael Geschwind, MD, PhD United States
Multi-center evaluation of improved RT-QuIC diagnostic assays for Creutzfeldt-Jakob and other human prion diseases Michael Geschwind, MD, PhD United States
Early Diagnosis of Human Prion Disease Michael Geschwind, MD, PhD United States
A Multicenter, Multinational, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Laquinimod (0.5, 1.0 and 1.5 mg/day) as Treatment in Patients with Huntington's Disease Michael Geschwind, MD, PhD United States
TLC-Pre-gPrd: Tracking Longitudinal Change in Presymptomatic genetic Prion Disease Michael Geschwind, MD, PhD United States
Predicting progression of human prion disease Michael Geschwind, MD, PhD United States
Neurobiological Predictors of Huntington's Disease (Predict-HD) Michael Geschwind, MD, PhD United States
International Fellowship Program in Drug Development United States
Pharmacogenomics of Membrane Transporters United States
Endogenous Biomarkers United States
Systems Pharmacology Approaches to Understanding Drug Induced Weight Gain United States
Development of Targeted Anti-Cancer Platinum Analogs United States
Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol United States
Comprehensive Assay Platform and Database for Drug Transporter Interaction Studies United States
Development of Transporter Targeted Platinum Drugs for Neuroblastoma United States
Tenofovir Kidney Toxicity Study United States
Center for Tobacco Control Research and Education Week Long International Training Program Stanton Glantz, PhD United States
Analysis of Tobacco Industry Documents Stanton Glantz, PhD United States
Postdoctoral training in tobacco control Stanton Glantz, PhD United States
Effect of Tobacco Advocacy at the State Level Stanton Glantz, PhD United States
Improved Models to Inform Tobacco Product Regulation Stanton Glantz, PhD United States
Effect of Tobacco Advocacy at the State Level Stanton Glantz, PhD United States
Center for Tobacco Control Research and Education Week Long International Training Program Stanton Glantz, PhD United States
Improved Models to Inform Tobacco Product Regulation Stanton Glantz, PhD United States
Tobacco Digital Library and Academic Center Grant Stanton Glantz, PhD United States
Integrated Health, Behavioral and Economic Research on Current and Emerging Tobacco Products Stanton Glantz, PhD United States
The New York Pepline Ronald Goldschmidt, MD United States
National HIV Training and Technical Cooperative Agreements-Focus Area: HIV/AIDS Medical Homes Ronald Goldschmidt, MD United States
Health Marketing Services for the CDC Act Against AIDS campaigns: HIV Screening Standard Care for Primary Care Physicians (HSSC) & One Test Two Lives (OTTL) for Obstetrical Providers Ronald Goldschmidt, MD United States
Monitoring and Evaluating the State Legislative/Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-care Settings Ronald Goldschmidt, MD United States
The New York PEPline Ronald Goldschmidt, MD United States
AIDS Education and Training Center, National Clinician Consultation Center Ronald Goldschmidt, MD United States
National HIV/AIDS Clinicians' Consultation Center Ronald Goldschmidt, MD United States
Monitoring and Evaluating the State Legislative /Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-Care Settings Ronald Goldschmidt, MD United States
The California Substance Use Line Ronald Goldschmidt, MD United States
AIDS Education and Training Center, Telehealth Training Centers Program Ronald Goldschmidt, MD United States
National HIV/AIDS Clinicians' Consultation Center Ronald Goldschmidt, MD United States
Malaria Serology evaluation Bryan Greenhouse, MD United States
Mentoring translational scientists in international infectious disease research Bryan Greenhouse, MD United States
Sarlo Award for Excellence in Teaching for the AIDS Research Institute at UCSF John Greenspan, BDS, PhD United States
For the Sarlo Teaching Award of the UCSF AIDS Research Institute John Greenspan, BDS, PhD United States
Oral Manifestations of AIDS John Greenspan, BDS, PhD United States
Western Oral Research Consortium: Career Development John Greenspan, BDS, PhD United States
Teaching in Excellence Award for the AIDS Research Institute John Greenspan, BDS, PhD United States
Neuropathological changes underlying clinical heterogeneity in Alzheimer disease United States
NSF REU in Molecular Biosciences United States
Mutational Analysis of E. Coli Core RNA Polymerase United States
Global Genetic Interaction Profiling in Prokaryotes United States
Function and Pathway Analysis Using Systems-Level Approaches in Prokaryotes United States
Regulation of the Heat Shock Response in E. coli United States
Dynamic Modeling of the Hepatitis C Epidemic in Injection Drug Users Judith Hahn, PhD, MD United States
Acute Hepatitis C Infection in Young Injectors (incoming sub) Judith Hahn, PhD, MD United States
Integrating Alcohol Screening and Brief Intervention into HIV Care Judith Hahn, PhD, MD United States
Oral Drug Treatment for Enhanced Immune Control over HIV Replication United States
Regulatory T Cell Influence on Infant and Adult Immune Responses to HIV United States
Administration of an ACE-Inhibitor to Decrease the Latent Reservoir United States
Treating HIV-Infected Elite Controllers as a Model of HIV Remission United States
Feasibility of a Point-Of-Care CD4+ Test United States
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients United States
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals United States
Virologic and Host Factors Contributing to HIV Control in Elite Controllers United States
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study United States
Treatment to Reduce Inflammation and Improve Immune Recovery Among Older HIV Patients United States
Treating HIV-Infected Elite Controllers as a Model of HIV Remission United States
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding) Diane Havlir, MD United States
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD United States
Adult AIDS Clinical Trials Unit (AACTU) Diane Havlir, MD United States
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s) Diane Havlir, MD United States
UCSF HIV/AIDS Management Training Programs Diane Havlir, MD United States
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) Diane Havlir, MD United States
Productive and Latent HIV Infection in Gut Mucosal Reservoirs Diane Havlir, MD United States
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study Diane Havlir, MD United States
AIDS Clinical Trials Group; Protocol Funds Diane Havlir, MD United States
Getting to Zero Coordinator/ SFPHF Diane Havlir, MD United States
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Diane Havlir, MD United States
Training in HIV Translational Research Diane Havlir, MD United States
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane Havlir, MD United States
Task Order Supplement to A5267 Diane Havlir, MD United States
Task Order # 6: Supplement to SSS A5257 Diane Havlir, MD United States
Training in HIV Translational Research Diane Havlir, MD United States
Heals Endowment Fund at the East Bay Community Foundation Diane Havlir, MD United States
ACTG A5335s Specialty Lab Diane Havlir, MD United States
Effect of Pitavastatin on Kidney Function in HIV-infected Persons Diane Havlir, MD United States
AIDS Research and Services at SF General Hospital Diane Havlir, MD United States
AIDS Research and Services at SFGH Diane Havlir, MD United States
Neurological AIDS Research Consortium Diane Havlir, MD United States
Task Order # 7: Supplement to SSS A5254 Diane Havlir, MD United States
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 Diane Havlir, MD United States
UCSF HIV Clinical Trials Unit Diane Havlir, MD United States
Task Order # 9: Supplement to SSS A5272 Diane Havlir, MD United States
Task Order Agreement No. CRB-DCR01-S-09-00325 Diane Havlir, MD United States
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) Diane Havlir, MD United States
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD United States
AIDS Clinical Trials Group (ACTG) TTSG Services Diane Havlir, MD United States
SFBay CTU Diane Havlir, MD United States
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) Diane Havlir, MD United States
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) Diane Havlir, MD United States
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position Diane Havlir, MD United States
Training in HIV Translational Research Diane Havlir, MD United States
Unintended Pregnancy among Young Latinos in Rural Areas United States
Pelvic Examination Practices of Obstetrician-Gynecologists in the United States United States
Women's Reproductive Health Care in the Transition from Adolescence to Adulthood United States
TBRU: Tuberculosis Research Unit, Case Western Reserve University Philip Hopewell, MD United States
Master Agreement: Tuberculosis Epidemiologic Studies Consortium Philip Hopewell, MD United States
Core Prevention and Control Project Philip Hopewell, MD United States
Targeted Testing and Treatment of Latent TB Infection Philip Hopewell, MD United States
Tuberculosis Training Scholarships (TBTS) Philip Hopewell, MD United States
Evaluation of Smear Microscopy Methods Philip Hopewell, MD United States
Regional Capacity Building in Low Incidence Areas Philip Hopewell, MD United States
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. Tuberculosis Philip Hopewell, MD United States
Task Order #22 Assessing the Integration of Social Network Analysis into Tuberculosis Contact Investigation Practice Philip Hopewell, MD United States
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD United States
Population-Based Molecular Epidemiology of Tuberculosis in San Francisco Philip Hopewell, MD United States
HQHIV1003203 Philip Hopewell, MD United States
Population-Based Molecular Epidemiology of Tuberculosis Philip Hopewell, MD United States
Model Tuberculosis Education and Training Center Philip Hopewell, MD United States
Master Agreement: Tuberculosis Indefinite Quantity Contract (TB IQC) Philip Hopewell, MD United States
Regional Training and Medical Consultation Center Philip Hopewell, MD United States
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD United States
Regional TB Training and Medical Consultation Center (RTMCC) Philip Hopewell, MD United States
Systematic Reviews of the Scientific Bases of Antituberculosis Chemotherapy ("Dogma" Review) Philip Hopewell, MD United States
Coordination of the Development of Tuberculosis Contact Investigation Policy Philip Hopewell, MD United States
Systematic Review Series on "Antibody and Antigen Detection for the Immunodiagnosis of Tuberculosis" Philip Hopewell, MD United States
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV United States
Effect of low dose methotrexate on endothelial function and inflammation in HIV United States
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV United States
Epidemiology and Pathogenesis of Pulmonary Hypertension in HIV Patients United States
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) United States
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection United States
Effect of low dose methotrexate on endothelial function and inflammation in HIV United States
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV United States
Randomized, Double-Blind Placebo-Controlled Phase 2a Study to Assess the Effect of CCR2 Antagonism by MLN1202 on Atherosclerotic Inflammation in Subjects with Stable Atherosclerotic Cardiovascular Disease Using FDG PET/CT Imaging United States
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans United States
Cardiovascular Inflammation Reduction Trial (CIRT) United States
HIV Viral Reservoirs and Monocyte Activation in HIV-Associated Atherosclerosis United States
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study Laurence Huang, MD United States
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD United States
Molecular Epidemiology of Human P. Carinii Pneumonia Laurence Huang, MD United States
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. Laurence Huang, MD United States
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes Laurence Huang, MD United States
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD Uganda, United Kingdom, United States
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial) Laurence Huang, MD United States
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease Laurence Huang, MD United States
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV Laurence Huang, MD United States
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l)) Laurence Huang, MD United States
Evaluate Serum-Based Assay for Pneumocystis Pneumonia Diagnosis Laurence Huang, MD United States
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll) Laurence Huang, MD United States
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV Laurence Huang, MD United States
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter Hunt, MD United States
Mesalamine to Reduce T Cell Activation in HIV Infection Peter Hunt, MD United States
Investigating Mechanisms of HIV Persistence in the Gut Peter Hunt, MD United States
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter Hunt, MD United States
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection Peter Hunt, MD United States
HIV-Specific T-cell Responses in Rectal Mucosa Peter Hunt, MD United States
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order Peter Hunt, MD United States
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter Hunt, MD United States
Intestinal MAIT Cells in HIV Infection Peter Hunt, MD United States
The Determinants of T Cell Activation in HIV Infection Peter Hunt, MD United States
HIV Pathogenesis and Immunity in Viremic Non-Progressors Peter Hunt, MD United States
Immunologic determinants of age-related macular degeneration Peter Hunt, MD United States
HIV-Specific T-Cell Responses in Rectal Mucosa Peter Hunt, MD United States
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order Peter Hunt, MD United States
Determinants of Functional Immune Defects in Treated HIV Infection and Aging Peter Hunt, MD United States
Valganciclovir to Reduce T Cell Activation in HIV Infection Peter Hunt, MD United States
Impact of Cannabis on Inflammation and Viral Persistence in Treated HIV/SIV Peter Hunt, MD United States
Cervical Maturity, Mucosal Immunity, and Chlamydia trachomatis Infections United States
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART United States
Investigation of M. tuberculosis Cytochrome P450 Involvement in Cholesterol Utilization United States
Adherence Improvement & Measurement (AIM) System United States
Compassionate Use of Marqibo for the Treatment of Refractory T-Cell Acute Lymphoblastic Leukemia Lawrence Kaplan, MD United States
Fitness Cost and Compensation in Quinolone-Resistant Mycobacterium tuberculosis Midori Kato-Maeda, MD United States
CDA - Improving the Diagnosis and Treatment of Acanthamoeba Keratitis Jeremy Keenan, MD, MPH United States
Planning Grant for Parasitic Ulcer Treatment Trial Jeremy Keenan, MD, MPH United States
Traineeships in AIDS Prevention Studies Susan Kegeles, PhD United States
HIV Translation Research for Young African American MSM Susan Kegeles, PhD United States
Mpowerment Project Training Agreement Susan Kegeles, PhD United States
HIV Prevention for African American Down Low Men Susan Kegeles, PhD United States
NIMH Collaborative HIV/STD Prevention Trial Susan Kegeles, PhD Peru, United States
Moving a Research-based Intervention into Practice Susan Kegeles, PhD United States
Community Mobilization to Improve the HIV/AIDS Continuum of Care among Black Men Susan Kegeles, PhD United States
HIV Prevention for Transgender Individuals Susan Kegeles, PhD United States
Web-Based, Structural HIV Prevention in MSM's Networks Susan Kegeles, PhD United States
Faith-based HIV Prevention for African American MSM Susan Kegeles, PhD United States
Mpowerment Project Training Agreement Susan Kegeles, PhD United States
Traineeships in AIDS Prevention Studies Susan Kegeles, PhD United States
Moving a Research-Based Intervention into Practice Susan Kegeles, PhD United States
Multilevel HIV Prevention Intervention for Young African American Men Susan Kegeles, PhD United States
Moving a Research-Based Intervention into Practice Susan Kegeles, PhD United States
HIV Prevention for African American Down Low Men Susan Kegeles, PhD United States
Community Mobilization to Improve the HIV/AIDS Continuum of Care Among Black Men Susan Kegeles, PhD United States
Community-level HIV Prevention Intervention for Young Black Men Susan Kegeles, PhD United States
Mpowerment Project Training Agreement Susan Kegeles, PhD United States
Traineeships in AIDS Prevention Studies Susan Kegeles, PhD United States
Calico Master Collaboration Agreement Regis Kelly, MD United States
NSW-QB3 Rosenman Institute Scholarship Program Regis Kelly, MD United States
Hoffmann-La Roche LTD Service Agreement Regis Kelly, MD United States
BioSF Program Regis Kelly, MD United States
Novartis Corporation Service Agreement Regis Kelly, MD United States
Bayer Service Agreement Regis Kelly, MD United States
QB3-UCSF Pfizer Collaboration Regis Kelly, MD United States
Antibodies to Synaptic Vesicles Regis Kelly, MD United States
QB3 Entrepreneurship Programs Regis Kelly, MD United States
Funding-NSW-QB3 Rosenman Institute Scholarship Program Regis Kelly, MD United States
Translational Studies Linking Aging and Cancer Cynthia Kenyon, PhD United States
Identification of a Viral Pathogen in Nematodes Cynthia Kenyon, PhD United States
AI452-020-0092: Phase 3 Blinded Randomized Study of Peginterferon Lambda-1a and Ribavirin Compared to Peginterferon Alfa-2a and Ribavirin, Each Administered with Telaprevir in Subjects with Genotype-1 Chronic Hepatitis C who are Treatment-naïve or Re Mandana Khalili, MD United States
Patients' HBV Knowledge, Attitudes, Barriers to HBV Care and HBV Treatment Mandana Khalili, MD United States
A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Adults with Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection Mandana Khalili, MD United States
A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed Mandana Khalili, MD United States
HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network-A Longitudinal, Observational Study Mandana Khalili, MD United States
A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Ledipasvir/Sofosbuvir in Subjects with Genotype 1, 4, 5 and 6 Chronic HCV Infection Who are on Dialysis for End Stage Renal Disease Mandana Khalili, MD United States
Insulin Resistance in HCV Infection Mandana Khalili, MD United States
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis Mandana Khalili, MD United States
HBV/HIV Co-Infection Research Network Mandana Khalili, MD United States
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD United States
Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus Mandana Khalili, MD United States
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults with Compensated Chronic Hepatitis B Mandana Khalili, MD United States
Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B Mandana Khalili, MD United States
PEGASYS plus Copegus in treatment-naïve Latino patients with chronic hepatitis C-genotype 1, as compared to treatment-naïve non-Latino White patients with chronic hepatitis C-genotype 1 Mandana Khalili, MD United States
Host and Viral Predictors of Prediabetes in at-risk Latinos with Chronic Hepatitis C (HCV) Mandana Khalili, MD United States
747-303: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of beticholic Acid in Subjects with Nonalcoholic Steatohepatitis Mandana Khalili, MD United States
Screening and Management of Chronic Hepatitis B Virus Infection: A Survey of San Francisco Health Care Providers Mandana Khalili, MD United States
GS-US-367-1172: A Phase 3, Global, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination for 8 Weeks Compared to Sofosbuvir/Velpatasvir for 12 Weeks in Direct-Acting Mandana Khalili, MD United States
Hcv-Induced Alterations in Glucose Metabolism Mandana Khalili, MD United States
Hepatocellular Carcinoma Screening Practices in Hepatitis B (HBV) Infected Asian Americans Mandana Khalili, MD United States
Mentoring Multidisciplinary Patient-Oriented Research in Viral Hepatitis Mandana Khalili, MD United States
GS-US-248-0122: A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection Mandana Khalili, MD United States
Alcohol's impact on immunological and virological profiles in HIV patients Mandana Khalili, MD United States
Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos Mandana Khalili, MD United States
Innate Immunity and Autophagy in Elite Controllers United States
Immunological Detection and Control of Experimental Uncomplicated Malaria United States
Immunological Detection and Control of Experimental Uncomplicated Malaria United States
Studies of Ocular Complications of AIDS (SOCA) United States
Proteomic Analysis of Antigenic Switching in the Malaria Parasite United States
Preparing Residents for the Changing Practice of Dermatology through Developing a Teledermatology Curriculum United States
JCF/Bransten Grant United States
Role of Innate Immunity in Controlling HIV Infection United States
Immunologic and Virologic Features of Early HIV Infection United States
Protection from HIV Infection in Intravenous Drug Users United States
Role of Innate Immunity in Controlling HIV Infection United States
Role of Innate Immunity in Controlling HIV Infection United States
Identification of the CD8+ Cell Anti-HIV Factor (CAF) United States
Subcontract from UFL Prime: HIV/FIV-Cat-Model: A model to identify vaccine epitopes United States
Role of Innate Immunity in Controlling HIV Infection United States
Identification of the CD8 Cell Anti-HIV Factor (CAF) United States
HIV cure with CCR5 (-) human IPS hematopoietic stem cells United States
UCSF AIDS Research Training Program United States
HIV cure with CCR5 negative human IPS hematopoietic stem cells United States
Identification of the CD8+ Cell Antiviral Factor (CAF) United States
Characterizing Natural Product Permeability and Bioactivity United States
Tipping Point Community-Addressing the Links Between Trauma and Poverty: A Program of Training and Early Intervention Alicia Lieberman, PhD United States
Consultation, Intervention and Training in Perinatal Mental Health for Medical Providers Alicia Lieberman, PhD United States
Beyond Centering Families - Perinatal Mental Health Services to SFGH Providers Alicia Lieberman, PhD United States
UCSF Child and Adolescent Service Alicia Lieberman, PhD United States
Helping Young Children Traumatized by Parental Separation Alicia Lieberman, PhD United States
Early Trauma Treatment Network: Improving Access and Standard of Care for Young/Preschool Children Alicia Lieberman, PhD United States
Infancy and Early Childhood Mental Health Consortium: Building and Sustaining a Regional and National Workforce for Immediate and Long-Term Impact Alicia Lieberman, PhD United States
Early Trauma Treatment Network: Raising the Standard of Care for Young Children 0-5 Alicia Lieberman, PhD United States
The Early Trauma Treatment Network Alicia Lieberman, PhD United States
Infant Mental Health Training: The Harris Professional Development Network Alicia Lieberman, PhD United States
Child-Parent Psychotherapy Training and Dissemination Alicia Lieberman, PhD United States
Preschooler Witnesses of Domestic Violence Alicia Lieberman, PhD United States
Child-Parent Intervention with Marital Violence Sequelae Alicia Lieberman, PhD United States
Phase I Dissemination of Child-Parent Psychotherapy in Minnesota Alicia Lieberman, PhD United States
UCSF/SFGH Department of Psychiatry- CBHS IPP (Infant-Parent Program) Alicia Lieberman, PhD United States
Tipping Point Community-Addressing the Links Between Trauma and Poverty: A Program of Training and Early Intervention Alicia Lieberman, PhD United States
Infant Parent Program: HSA-DHS (2013-2018) Alicia Lieberman, PhD United States
Tipping Point Community-Addressing the Links Between Trauma and Poverty: A Program of Training & Early Intervention Alicia Lieberman, PhD United States
Preschooler Witnesses of Domestic Violence Alicia Lieberman, PhD United States
Rapid Support and Housing for Families Alicia Lieberman, PhD United States
UCSF Child Trauma Research Program Alicia Lieberman, PhD United States
Addressing the Links Between Trauma and Poverty: A Program of Training & Early Intervention Alicia Lieberman, PhD United States
Child Trauma Research Program: Building System Capacity in Evidence-Based Treatment for Traumatized Infants and their Families Alicia Lieberman, PhD United States
IPP Mission Neighborhood Promise Alicia Lieberman, PhD United States
Child-Parent Psychotherapy: Training Minnesota Clinicians Alicia Lieberman, PhD United States
Mental Health Provider Training to the Jewish Family and Children's Services (JFCS) Alicia Lieberman, PhD United States
StarVista Early Childhood Mental Health Consultation Alicia Lieberman, PhD United States
Infectious and inflammatory eye disease epidemic detection and seasonality Thomas Lietman, MD United States
Digital Detection of Infectious Eye Epidemics Thomas Lietman, MD United States
Innovation Challenge CDC Sheri Lippman, PhD, MPH United States
CD4+ T Cell Receptors in Leishmaniasis Richard Locksley, MD United States
Initiation of allergic immunity by parasites Richard Locksley, MD United States
Initiation of Allergic Immunity by Parasites Richard Locksley, MD United States
Parasite Immunity Orchestrated by Th2 Cells Richard Locksley, MD United States
Initiation of allergic immunity by parasites Richard Locksley, MD United States
Epithelial chitinase and lung homeostasis Richard Locksley, MD United States
Clinical Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis (ALS) United States
Multicenter ALS Cohort Study of Oxidative Stress and Disease Progression United States
ALS Center of Excellence at UCSF United States
The Efficacy of Intrathecal Baclofen for Spasticity in Primary Lateral Sclerosis United States
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne Luetkemeyer, MD United States
GSK_201585: Phase III, randomized, multicenter, parallel-group, non inferiority, open-label study evaluating the efficacy, safety, & tolerability of switching to long-acting cabotegravir plus long acting rilpivirine from current INI,NNRTI, or PI-based ART Anne Luetkemeyer, MD United States
GS_US_342-1139: Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks with Sofosbuvir and Ribavirin for 12 Weeks in Subjects with Chronic Genotype 2 HCV Infecti Anne Luetkemeyer, MD United States
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy (ACTG) A5260s Anne Luetkemeyer, MD United States
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne Luetkemeyer, MD United States
ACTG A5294: A Prospective, Phase III Open-Label Study of Response-Guided Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects Anne Luetkemeyer, MD United States
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C Anne Luetkemeyer, MD United States
ACTG, AIDS Clinical Trials Research Group - A5289 and A5255 Anne Luetkemeyer, MD United States
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Anne Luetkemeyer, MD United States
ASN100-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of a Single Dose of ASN100 for the Prevention of Staphylococcus aureus Pneumonia in Heavily Colonized, Mechanically Ventilated Subjects Anne Luetkemeyer, MD United States
Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination with Ribavirin and Daclatasvir for Treatment of Chronic HCV Infection with Treatment Naïve Genotypes 1, 2, 3 or 4 in Subjects Coinfected with HIV-1 Anne Luetkemeyer, MD United States
GS-US-380-4030: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching from a Regimen of Dolutegravir and Either Emtricitabine/Tenofovir Alafenamide or Emtricitabine/Tenofovir Disoproxil Fumarate to a Fixed Dose Co Anne Luetkemeyer, MD United States
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne Luetkemeyer, MD United States
Pfizer A4001027: Observational Phase Extension Anne Luetkemeyer, MD United States
A Probe to Evaluate the Safety, Tolerability & Immunogenicity of the MRK Adenovirus Serotype 5 Vector Human Immunodeficiency Virus Type 1 gag Vaccine in HIV-1 Infected Anne Luetkemeyer, MD United States
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options Anne Luetkemeyer, MD United States
MK-3682B-037-00A: Phase 3 Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682B (Grazoprevir/Ruzasvir/Uprifosbuvir) in Participants with Chronic Hepatitis C Virus Genotype 3 Infection Anne Luetkemeyer, MD United States
Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Coadministered with Ribavirin in Adults with Genotype 1 Chronic HCV and HIV Anne Luetkemeyer, MD United States
M14-730 (EXPEDITION-2): A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection Anne Luetkemeyer, MD United States
Metabolic Substudy of A5257, CIMT/FMD Repeat Scans (ACTG A5260s:) Anne Luetkemeyer, MD United States
GS-US-183-0130: A Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents in the Treatment of HIV-1 Infected Subjects Anne Luetkemeyer, MD United States
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne Luetkemeyer, MD United States
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne Luetkemeyer, MD United States
Gilead GS-US-236-0102 Anne Luetkemeyer, MD United States
ViiV Healthcare A4001098 Anne Luetkemeyer, MD United States
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions Anne Luetkemeyer, MD United States
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay Anne Luetkemeyer, MD Uganda, United States
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of GS-7977 plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) Coinfected Subjects (GS-US-334-0123) Anne Luetkemeyer, MD United States
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement Anne Luetkemeyer, MD United States
Metabolic Impact of Fructose Restriction in Obese Children Robert Lustig, MD United States
Congenital Adrenal Hyperplasia and Primary Congenital Hypothyroidism Testing Robert Lustig, MD United States
DDT and PBDE Exposure, Puberty Onset, and Neurodevelopment in 9-Year-Old Children Robert Lustig, MD United States
Prevention of Emergence of Antibiotic Resistant P. aeruginosa United States
NKT Cells Recognize and Respond to Microbes at Mucosal Surfaces United States
The House Dust Fungal Microbiome - Influences and Effects United States
Sinus Microbiome Restoration Study United States
Probiotic Outcomes of Enteric Microbiota United States
Pets and the Infant Microbiome: Effect on Immune Maturation and Atopic Asthma United States
Analysis of Urban Aerosols in Major U.S. Cities - Implications for Asthmatic Airways United States
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation United States
Sinusitis in Children and the Nasopharyngeal Microbiome United States
Project 2: Effect of Humanized Anti Pcrv Antibody on Total Bacterial Community Composition of Adult Patients with Ventilator-Associated Pneumonia United States
Resequencing Microarray for Rapid Detection and Antimicrobial Resistance Profiling United States
Unsolicited R24 for the CFAR - Network of Integrated Clinical Sciences (CNICS) Jeffrey Martin, MD, MPH United States
NAAccord (CHK-UP on HIV Supplement) Jeffrey Martin, MD, MPH United States
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey Martin, MD, MPH United States
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey Martin, MD, MPH United States
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey Martin, MD, MPH United States
Cohort Study of Patients Receiving Long-Term Combination Therapy [II] Jeffrey Martin, MD, MPH United States
Can a Teledermatology Triage Program Succeed in an Insured Health Care System? Toby Maurer, MD United States
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging Toby Maurer, MD United States
Effects of Maraviroc on HIV-related Kaposi Sarcoma Toby Maurer, MD United States
Immunosenescence Profiles of Atypical Cases of Kaposi Sarcoma in Well-Controlled HIV Infection Toby Maurer, MD United States
Establishing the Dermatology Component of e-Referral at SFGH Toby Maurer, MD United States
HIV, Hepatitis C, and Pruritus: Data from the Women's Interagency HIV Study Toby Maurer, MD United States
Opioids & HIV Medications: Interactions in Drug Abusers United States
Disulfiram Interactions With HIV Medications: Clinical Implications United States
Role of Buprenorphine in Improving Clinical Care in Opioid Addiction and HIV United States
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection United States
Design of an Effective Vaccine against HIV: An Alternative Hypothesis Mike McCune, MD, PhD United States
Novel flow cytometry-based assay for HIV-infected cells Mike McCune, MD, PhD United States
Inflammation and HIV Persistence Mike McCune, MD, PhD United States
Early Antiretroviral Therapy and HIV Remission in Perinatal Infection Mike McCune, MD, PhD United States
In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies Mike McCune, MD, PhD United States
HIV Proteomic Center for Host-Viral Responses Characterization Mike McCune, MD, PhD United States
Detection and Measurement of the HIV Reservoir Mike McCune, MD, PhD United States
Vitamin A Metabolism and Helminth Infection Mike McCune, MD, PhD United States
Assessing Laboratory Correlates of Immune Protection Mike McCune, MD, PhD United States
HIV Proteomic Center for Host-Viral Responses Characterization Mike McCune, MD, PhD United States
NIH Director's Pioneer Award Mike McCune, MD, PhD United States
Recent Thymic Emigrants of the CD4 T-Cell Lineage Mike McCune, MD, PhD United States
Interruption of Maternal-Fetal Transmission of HIV Mike McCune, MD, PhD United States
Layering of the Human Immune System, Viral Infections, and Childhood Asthma Mike McCune, MD, PhD United States
Thymic Function in Adults With HIV-1 Disease Mike McCune, MD, PhD United States
Human Immune System Layering and the Neonatal Response to Vaccines Mike McCune, MD, PhD United States
Use of r-hGh to Enhance Thymopoiesis and to Facilitate Immune Restoration in Individuals Infected with HIV-1 Mike McCune, MD, PhD United States
HIV Effects on the Central Hematolymphoid System Mike McCune, MD, PhD United States
The UW Asthma and Allergic Diseases Cooperative Research Center Mike McCune, MD, PhD United States
Timing of ART and homeostasis of the persistent HIV reservoir in the adult Mike McCune, MD, PhD United States
Bay Area Hepatitis C Cooperative Research Center Mike McCune, MD, PhD United States
Design of an Effective Vaccine against HIV: An Alternative Hypothesis Mike McCune, MD, PhD United States
The Impact of Tolerance in the Newborn on Lentiviral Infection Mike McCune, MD, PhD United States
HIV Effects on the Central Hematolymphoid System Mike McCune, MD, PhD United States